![Patrick Baeuerle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Baeuerle
Directeur/Membre du Conseil chez
TeGenero AG
Profil
Patrick A. Baeuerle is the founder of Maverick Therapeutics, Inc., founded in 2016.
Dr. Baeuerle is the founder of Werewolf Therapeutics, Inc., founded in 2017.
Dr. Baeuerle is the founder of iOmx Therapeutics AG, founded in 2016.
Dr. Baeuerle was the founder of Harpoon Therapeutics, Inc., founded in 2015, and served as Director from 2016 to 2020.
Dr. Baeuerle was the founder of TCR² Therapeutics, Inc., founded in 2015, and served as Independent Director from 2015 to 2021.
Dr. Baeuerle was the founder of Cullinan Oncology LLC, founded in 2016, and served as Chief Scientific Officer-Biologics from 2016 to 2022.
Dr. Baeuerle was the founder of Cullinan Therapeutics, Inc., founded in 2016, and served as Chief Scientific Officer from 2022 to 2023.
Dr. Baeuerle is also the founder of Crossbow Therapeutics, Inc...
Dr. Baeuerle is currently Director at TeGenero AG since 2009.
Dr. Baeuerle is Executive Partner at MPM BioImpact LLC since 2015.
Dr. Baeuerle is a Member of the European Molecular Biology Organization.
Formerly, Dr. Baeuerle was Chairman-Biochemistry & Professor at the University of Freiburg from 1994 to 1996.
Dr. Baeuerle was Director-Drug Discovery at Tularik, Inc. from 1996 to 1998.
Dr. Baeuerle was Head-Global Business at F.
Hoffmann-La Roche Ltd. from 1998 to 2000.
Dr. Baeuerle was Chief Scientific Officer at Micromet AG from 1998 to 2012.
Dr. Baeuerle was Vice President-Research & General Manager at Amgen Research (Munich) GmbH from 2012 to 2015.
Dr. Baeuerle was Chief Scientific Officer & Senior Vice President at Amgen Rockville, Inc. from 1998 to 2012.
Education includes a doctorate from Max-Planck-Institute for Molecular Genetics.
Dr. Baeuerle earned undergraduate and doctorate degrees from Ludwig-Maximilians-Universität München in 1987.
Postes actifs de Patrick Baeuerle
| Sociétés | Poste | Début |
|---|---|---|
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics | Directeur/Membre du Conseil | - |
European Molecular Biology Organization | Corporate Officer/Principal | 13/05/2010 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/04/2015 |
Anciens postes connus de Patrick Baeuerle
| Sociétés | Poste | Fin |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Fondateur | 08/06/2023 |
| TCR2 THERAPEUTICS INC. | Fondateur | 24/08/2021 |
| HARPOON THERAPEUTICS, INC. | Fondateur | 30/06/2020 |
Amgen Research (Munich) GmbH
 Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Produces copper and metal powders | Directeur Technique/Scientifique/R&D | 01/03/2015 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Directeur Technique/Scientifique/R&D | 01/03/2012 |
Formation de Patrick Baeuerle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Produces copper and metal powders | Producer Manufacturing |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics | Health Technology |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Molecular Biology Organization | |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Health Technology |
